Labels have meaning, particularly when entrepreneurs are making the key decisions of whether and when to add their first employees. In Part I of their look at the considerations involved with classifying workers as employees or independent contractors, Early Stage columnist Joe Boucher and legal...
Despite the sparse attendance at a recent Midwestern biotechnology conference, columnist Michael Rosen believes there is room for a major bioscience cluster here. In this edition of Yer Biotech Blues, he examines the key ingredients necessary to have a successful world-class bioscience cluster in the...
GE Healthcare will provide new imaging systems to the Vancouver Island Health Authority under an eight-year, $11 million agreement. The deal includes the purchase of 48 new ultrasound systems....
When it comes to technology, the British are more like Boston than Silicon Valley, as DEMO Letter columnist Chris Shipley has found on her trip across the pond. While getting a snapshot of the U.K. entrepreneurial scene, she has heard not one word about Web...
Third Wave Technologies reported a smaller net loss in 2006, and continues to grow its clinical diagnostic revenue and overall revenue, according to a year-end financial report. The company's $18.9 million loss, which translates to 45 cents per share, compares to the $22.3 million loss...
GenTel BioSciences has raised an additional $500,000 in angel capital to accommodate a new collaboration with a large pharmaceutical company, which officially will be announced next month. The commitment brings to $2 million the amount of capital raised from two Wisconsin investment networks. ...
Columnist Ogan Gurel knows the winners of the 2007 Medical Design Excellence Awards, but he's been sworn to secrecy until the winners are announced this spring. However, following his role as a judge in the contest, he provides a glimpse into the future of medical...
With businesses becoming increasingly dependent of information technology, it's vital for them to align IT with their business needs, opines Global Fusion columnist and WTN Editorial Director Mike Klein. More than one Wisconsin organization has done so with a corresponding alignment between IT and upper...
Gregg Fergus is probably the only professional who has ever flown from Madison to Silicon Valley just to reach the office, but his weekly commute is over. Fergus, who recently was named to the executive teams at Baird Venture Partners and Caden Biosciences, is counted...
Big Pharma has evolved into “Enormous Pharma” thanks to a six-stage deconstruction process of interconnected events, according to Yer Biotech Blues columnist Michael Rosen. Enormous Pharma will likely grow even larger as it is fed by global demographic trends and the need to conquer new...